# Claire Brown

> Claire Brown is a seed investor at Oxford Science Enterprises backing Biotechnology and Medical. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Oxford Science Enterprises](https://shizune.co/investors/profile/oxford-sciences-innovation)
- Location: Alderley Edge, United Kingdom
- Total investments: 3
- Last investment: May 2019
- Lead investor: 33%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/claire-brown-5bb9516/

Claire Brown is a seed investor at Oxford Science Enterprises in Alderley Edge focused on Biotechnology and Medical. Claire Brown is the Partner ( Life Sciences) at Oxford Science Enterprises. Claire Brown attended University of Glasgow.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 3 | 100% |
| Medical | 2 | 67% |
| Therapeutics | 2 | 67% |
| Health Care | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United Kingdom | 2 | 67% |
| United States | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Scripta Therapeutics | Scripta Therapeutics operates as a bio-tech company, that delivers transformative therapeutics through cutting edge technology. | $12M | Seed | Nov 13, 2025 |  |
| AlveoGene | AlveoGene is an innovative company focused on transforming rare respiratory disease outcomes using inhaled gene therapy. |  | Seed | Sep 14, 2023 |  |
| Rinri Therapeutics | Rinri Therapeutics is a provider of private biotechnology services intended to develop advanced regenerative stem cell-based therapies for the treatment of hearing loss. The company's stem cell technology replaces damaged or dead sensory cells of the inner ear, enabling doctors to restore hearing of patients. | $1.8M | Seed | May 20, 2019 |  |

3 of 3 investments shown.

## Co-investors
- [AlbionVC](https://shizune.co/investors/profile/albion-vc) — VC Fund, 1 deal together
- [Apollo Health Ventures](https://shizune.co/investors/profile/apollo-health-ventures) — VC Fund, 1 deal together
- [Boehringer Ingelheim Venture Fund](https://shizune.co/investors/profile/boehringer-ingelheim-venture-fund) — VC Fund, 1 deal together
- [Harrington Discovery Institute at University Hospitals](https://shizune.co/investors/profile/harrington-discovery-institute-at-university-hospitals) — VC Fund, 1 deal together
- [Old College Capital](https://shizune.co/investors/profile/old-college-capital) — VC Fund, 1 deal together
- [Oxford Science Enterprises](https://shizune.co/investors/profile/oxford-science-enterprises) — VC Fund, 1 deal together

## About Oxford Science Enterprises

VC Fund · Oxford, United Kingdom

Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking onchallenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.

5 contacts available at Oxford Science Enterprises.

| Name | Title | Profile |
| --- | --- | --- |
| Alexis Dormandy | Chief Executive Officer | https://shizune.co/investors/profile/alexis-dormandy |
| Alexis Zervoglos | Senior Partner (Technology) | https://shizune.co/investors/profile/alexis-zervoglos |
| Claire Brown | Partner ( Life Sciences) | https://shizune.co/investors/profile/claire-brown |
| Ekaterina Smirnyagina | Senior Partner and Head of Life Sciences | https://shizune.co/investors/profile/ekaterina-smirnyagina |
| David Norwood | Chairman | https://shizune.co/investors/profile/david-norwood |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Claire Brown invest in?

Claire Brown invests primarily in Biotechnology, Medical and Therapeutics startups, most often at Seed stage. Most of the 3 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Claire Brown last invest?

The most recent investment recorded for Claire Brown closed in May 2019. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co